Picture of Oncolytics Biotech logo

ONCY — Oncolytics Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: Oncolytics announces successful end-of-Phase 2 meeting with FDA for reolysin

Sept 18 (Reuters) - Oncolytics Biotech Inc  ONC.TO  
    * Oncolytics Biotech Inc - announces successful end-of-Phase 
2 meeting with FDA for reolysin in metastatic breast cancer 
    * Oncolytics Biotech Inc - FDA provided guidance that if 
study achieves its primary endpoint, then it will be only study 
required for BLA approval 
 
Source text for Eikon:  ID:nPnyn6QXa  
Further company coverage:  ONC.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Oncolytics Biotech

See all news